Advances in EGFR/HER2-directed clinical research on breast cancer.

Abstract excerpt

The discovery of the HER2 molecules has embarked a series of investigations on the efficacy and safety of different types of anti-HER2 therapies for treating breast cancer, with the clinical pathway requiring a more detailed, more precise, and more dynamics therapeutic approaches due to the heterogeneity of the disease. As the "do more" and "do less" approaches are becoming more important to personalize treatment...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biomedical Research
• Share to Disease Progression
• Share to Drug Resistance, Neoplasm